Evaluation of Anti-Elongation Factor-Tu (EF-Tu) Antibodies as a Potential Immunotherapeutic Approach to Combat Pseudomonas aeruginosa Infections in vivo
1 di 2
Replication and Viability of Recombinant Modified Vaccinia Virus
Ankara 44/47.1 and 51.1 in Mammalian Cells